GB0408955D0 - Pteridine derivatives useful as pharmaceutical ingredients - Google Patents

Pteridine derivatives useful as pharmaceutical ingredients

Info

Publication number
GB0408955D0
GB0408955D0 GBGB0408955.3A GB0408955A GB0408955D0 GB 0408955 D0 GB0408955 D0 GB 0408955D0 GB 0408955 A GB0408955 A GB 0408955A GB 0408955 D0 GB0408955 D0 GB 0408955D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical ingredients
derivatives useful
pteridine derivatives
pteridine
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0408955.3A
Other versions
GB2413324A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
4 AZA Bioscience NV
Original Assignee
4 AZA Bioscience NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4 AZA Bioscience NV filed Critical 4 AZA Bioscience NV
Priority to GB0408955A priority Critical patent/GB2413324A/en
Publication of GB0408955D0 publication Critical patent/GB0408955D0/en
Priority to PCT/BE2004/000124 priority patent/WO2005021003A2/en
Priority to AT04761485T priority patent/ATE376421T1/en
Priority to US10/595,126 priority patent/US7501513B2/en
Priority to DE602004009696T priority patent/DE602004009696T2/en
Priority to SI200430569T priority patent/SI1658081T1/en
Priority to CA002534151A priority patent/CA2534151A1/en
Priority to JP2006524183A priority patent/JP2007533610A/en
Priority to AU2004267885A priority patent/AU2004267885A1/en
Priority to EP04761485A priority patent/EP1658081B1/en
Priority to PL04761485T priority patent/PL1658081T3/en
Priority to DK04761485T priority patent/DK1658081T3/en
Priority to ES04761485T priority patent/ES2295897T3/en
Priority to PT04761485T priority patent/PT1658081E/en
Priority to PL04765120T priority patent/PL1663244T3/en
Priority to DE602004008304T priority patent/DE602004008304T2/en
Priority to AU2004271721A priority patent/AU2004271721A1/en
Priority to US10/595,161 priority patent/US20070004721A1/en
Priority to EP04765120A priority patent/EP1663244B1/en
Priority to PT04765120T priority patent/PT1663244E/en
Priority to ES04765120T priority patent/ES2293324T3/en
Priority to DK04765120T priority patent/DK1663244T3/en
Priority to SI200430474T priority patent/SI1663244T1/en
Priority to JP2006525783A priority patent/JP2007533617A/en
Priority to AT04765120T priority patent/ATE369861T1/en
Priority to CA002534549A priority patent/CA2534549A1/en
Priority to PCT/EP2004/010198 priority patent/WO2005025574A2/en
Priority to SI200430499T priority patent/SI1673092T1/en
Priority to PCT/EP2004/011836 priority patent/WO2005039587A1/en
Priority to AU2004283479A priority patent/AU2004283479A1/en
Priority to DK04790649T priority patent/DK1673092T3/en
Priority to DE602004008312T priority patent/DE602004008312T2/en
Priority to ES04790649T priority patent/ES2293354T3/en
Priority to PT04790649T priority patent/PT1673092E/en
Priority to AT04790649T priority patent/ATE369862T1/en
Priority to CA002537224A priority patent/CA2537224A1/en
Priority to PL04790649T priority patent/PL1673092T3/en
Priority to EP04790649A priority patent/EP1673092B1/en
Priority to JP2006534724A priority patent/JP2007508355A/en
Publication of GB2413324A publication Critical patent/GB2413324A/en
Priority to US11/402,423 priority patent/US20070032477A1/en
Priority to CY20081100034T priority patent/CY1107264T1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/40—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0408955A 1998-12-28 2004-04-22 Pharmaceutically active pteridine derivatives Withdrawn GB2413324A (en)

Priority Applications (41)

Application Number Priority Date Filing Date Title
GB0408955A GB2413324A (en) 2004-04-22 2004-04-22 Pharmaceutically active pteridine derivatives
PT04761485T PT1658081E (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
CA002534151A CA2534151A1 (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
AT04761485T ATE376421T1 (en) 2003-08-29 2004-08-27 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES
US10/595,126 US7501513B2 (en) 1998-12-28 2004-08-27 Immunosuppressive effects of pteridine derivatives
DE602004009696T DE602004009696T2 (en) 2003-08-29 2004-08-27 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES
SI200430569T SI1658081T1 (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
PCT/BE2004/000124 WO2005021003A2 (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
JP2006524183A JP2007533610A (en) 2004-04-22 2004-08-27 Immunosuppressive effect of pteridine derivatives
AU2004267885A AU2004267885A1 (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
EP04761485A EP1658081B1 (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
PL04761485T PL1658081T3 (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
DK04761485T DK1658081T3 (en) 2003-08-29 2004-08-27 Immunosuppressive effects of pteridine derivatives
ES04761485T ES2295897T3 (en) 2003-08-29 2004-08-27 IMMUNODEPRESSING EFFECTS OF PTERIDINE DERIVATIVES.
PCT/EP2004/010198 WO2005025574A2 (en) 2003-09-12 2004-09-13 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES.
ES04765120T ES2293324T3 (en) 2003-09-12 2004-09-13 PTERIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATING TO TNF-ALPHA.
DE602004008304T DE602004008304T2 (en) 2003-09-12 2004-09-13 PTERIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO TNF-ALPHA
AU2004271721A AU2004271721A1 (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of septic shock and TNF-alpha-related diseases.
US10/595,161 US20070004721A1 (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases
EP04765120A EP1663244B1 (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of tnf-alpha-related diseases.
PT04765120T PT1663244E (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of tnf-alpha-related diseases.
PL04765120T PL1663244T3 (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of tnf-alpha-related diseases.
DK04765120T DK1663244T3 (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of TNF-alpha-related diseases
SI200430474T SI1663244T1 (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of tnf-alpha-related diseases.
JP2006525783A JP2007533617A (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of septic shock and TNF-α-related diseases
AT04765120T ATE369861T1 (en) 2003-09-12 2004-09-13 PTERIDINE DERIVATIVES FOR THE TREATMENT OF TNF-ALPHA-RELATED DISEASES
CA002534549A CA2534549A1 (en) 2003-09-12 2004-09-13 Pteridine derivatives for the treatment of septic shock and tnf-.alpha.-related diseases.
JP2006534724A JP2007508355A (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
AU2004283479A AU2004283479A1 (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
AT04790649T ATE369862T1 (en) 2003-10-17 2004-10-18 HETEROCYCLUS-SUBSTITUTED PTERIDINE DERIVATIVES AND THEIR USE IN THERAPY
SI200430499T SI1673092T1 (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
DK04790649T DK1673092T3 (en) 2003-10-17 2004-10-18 Heterocyclyl-substituted pteridine derivatives and their use in therapy
DE602004008312T DE602004008312T2 (en) 2003-10-17 2004-10-18 Heterocyclic-substituted pteridine derivatives and their use in therapy
ES04790649T ES2293354T3 (en) 2003-10-17 2004-10-18 PTERIDINE DERIVATIVES REPLACED BY HETEROCICLES AND ITS USE IN THERAPY.
PT04790649T PT1673092E (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
PCT/EP2004/011836 WO2005039587A1 (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
CA002537224A CA2537224A1 (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
PL04790649T PL1673092T3 (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
EP04790649A EP1673092B1 (en) 2003-10-17 2004-10-18 Heterocycle-substituted pteridine derivatives and their use in therapy
US11/402,423 US20070032477A1 (en) 2003-10-17 2006-04-12 Pteridine derivatives useful for making pharmaceutical compositions
CY20081100034T CY1107264T1 (en) 2003-08-29 2008-01-10 RESULTS OF PTERIDINE PRODUCERS 'IMMUNIZATION SUPPORT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0408955A GB2413324A (en) 2004-04-22 2004-04-22 Pharmaceutically active pteridine derivatives

Publications (2)

Publication Number Publication Date
GB0408955D0 true GB0408955D0 (en) 2004-05-26
GB2413324A GB2413324A (en) 2005-10-26

Family

ID=32344196

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0408955A Withdrawn GB2413324A (en) 1998-12-28 2004-04-22 Pharmaceutically active pteridine derivatives

Country Status (3)

Country Link
JP (1) JP2007533610A (en)
GB (1) GB2413324A (en)
PT (1) PT1658081E (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6093759B2 (en) * 2011-06-01 2017-03-08 ジャナス バイオセラピューティクス，インク． Novel immune system modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039129A1 (en) * 1998-12-28 2000-07-06 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
SE0003828D0 (en) * 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
GB2413324A (en) 2005-10-26
JP2007533610A (en) 2007-11-22
PT1658081E (en) 2008-01-15

Similar Documents

Publication Publication Date Title
IL191907A0 (en) Azepinoindole derivatives as pharmaceutical agents
IL176014A0 (en) Azepinoindole derivatives as pharmaceutical agents
IL190292A (en) Pyridopyrimidinone derivatives and pharmaceutical compositions comprising them
IL189737A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL180630A0 (en) Pyrrole derivatives as pharmaceutical agents
EP1765283A4 (en) Pharmaceutical compositions
IL178651A0 (en) Pharmaceutical compositions
IL177480A0 (en) Pharmaceutical composition
GB0408308D0 (en) Pharmaceutical compositions
ZA200700352B (en) Pyrrole derivatives as pharmaceutical agents
EP1805154A4 (en) Pharmaceutical compositions
EP1889613A4 (en) Pharmaceutical composition comprising vitamin k
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
HK1105358A1 (en) Solid pharmaceutical formulation
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
ZA200701931B (en) Pharmaceutical composition
GB0408955D0 (en) Pteridine derivatives useful as pharmaceutical ingredients
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
EP1747205A4 (en) Pharmaceutical compositions
GB0502792D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)